0001179110-15-006393.txt : 20150417
0001179110-15-006393.hdr.sgml : 20150417
20150417142322
ACCESSION NUMBER: 0001179110-15-006393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150415
FILED AS OF DATE: 20150417
DATE AS OF CHANGE: 20150417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W
CENTRAL INDEX KEY: 0001190273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 15777536
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
STREET 2: C/O GILEAD SCIENCES, INC.
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
edgar.xml
FORM 4 -
X0306
4
2015-04-15
0
0000882095
GILEAD SCIENCES INC
GILD
0001190273
BISCHOFBERGER NORBERT W
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
0
1
0
0
EVP, R&D and CSO
Common Stock
2015-04-15
4
M
0
70000
20.74
A
235168
D
Common Stock
2015-04-15
4
S
0
10239
103.0597
D
224929
D
Common Stock
2015-04-15
4
S
0
59761
103.9708
D
165168
D
Non-Qualified Stock Option (right to buy)
20.74
2015-04-15
4
M
0
70000
0
D
2017-05-08
Common Stock
70000
20000
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
Sale prices reported for the transactions reported here range from $102.47 to $103.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $103.48 to $104.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Norbert W. Bischofberger
2015-04-17